LIGHTSPEED MANAGEMENT COMPANY, L.L.C.
An institutional investment manager in MENLO PARK, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1702122.
- Reported value$2.40bn
- Positions8
Holdings: 8 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Space Exploration Techn CorpSPCX | CLASS A COM STK | 84615Q103 | 1,247 | 51.9% | 7,300,055 | New+7,300,055 | |
| Navan IncNAVN | CL A | 639193101 | 954 | 39.7% | 41,698,258 | Reduced−8,223,196 | |
| Personalis IncPSNL | COM | 71535D106 | 81.8 | 3.4% | 6,101,850 | Reduced−2,058,884 | |
| Odyssey Therapeutics IncODTX | COMMON STOCK | 67613T104 | 67.5 | 2.8% | 3,608,443 | New+3,608,443 | |
| Kodiak Ai Inc.KDK | COM | 500081104 | 37.3 | 1.6% | 7,340,475 | Unchanged | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 17.0 | 0.7% | 1,355,299 | Unchanged | |
| Diginex Ltd | ORD SHS | G28687112 | 0.3 | <0.1% | 176,618 | New+176,618 | |
| Figma IncFIG | CLASS A COM STK | 316841105 | 0.2 | <0.1% | 10,391 | Reduced−173,120 |
Sold out: 3 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Blend Labs IncBLND | CL A | 09352U108 | 0.0 | 0.0% | 0 | Sold out−23,127,237 | |
| Diginex Ltd | ORD SHS | G28687104 | 0.0 | 0.0% | 0 | Sold out−1,412,938 | |
| Servicenow IncNOW | COM | 81762P102 | 0.0 | 0.0% | 0 | Sold out−1,530,400 |
Source: SEC EDGAR, Form 13F-HR, accession 0001702122-26-000010 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.